mAbxience

🎉 We’ve reached 70,000 followers!    A big thank you to our growing LinkedIn community for supporting mAbxience’s mission of delivering high-quality, affordable biologic medicines to patients worldwide.   Every follower represents a shared belief in innovation, accessibility, and progress in healthcare. Together, we’re building greater awareness of our mission—and that helps us make a bigger impact every year. 🌍💊   Here’s to continuing this journey together! 🚀   #70kFollowers #ThankYou #Biopharma #Biosimilars #mAbxience #CDMO #HelpingPeopleLiveBetter

Have you had a chance to explore the comprehensive details of our CDMO services on our newly revamped webpage? If not, now is the perfect time to dive in! 🌟 🔗 Check out the details: https://lnkd.in/dc9RABui At mAbxience, we’re dedicated to supporting your biopharma projects with tailored solutions and world-class expertise at every stage—from development and manufacturing to rigorous testing. Our updated CDMO pages are designed to give you a clear overview of how we can partner with you to achieve your goals. 💬 Have questions or need more information about your specific project? Our team is here to help! Don’t hesitate to reach out—we’d love to discuss how we can collaborate to bring your vision to life. https://lnkd.in/dnM2dREq #CDMO #Biopharma #mAbxience #Partnerships #Biosimilars #Manufacturing #HealthcareSolutions

💡 At mAbxience, we’re always pushing the boundaries of biopharmaceutical development. We have streamlined manufacturing processes, using single-use bioreactors with flexible capabilities, for high operational efficiency. We can quickly switch between production runs, minimizing downtime, ensuring smooth changeovers and reducing the risk of cross-contamination thanks to pre-sterilized components.🔬✅ Curious how these technologies drive efficiency across biopharma? Don’t miss our recent blog post for more insights into how SUTs are transforming the industry! 👉 https://lnkd.in/dcMmt_wg #SingleUseBioreactors #FlexibleManufacturing #TechInBiotech #EfficientProcesses #mAbxience #BiopharmaceuticalManufacturing #Biotech

#Biosimilars hold incredible potential to improve #globalhealthcare access by providing more affordable alternatives to complex biologic drugs. At mAbxience, our mission is to make high-quality medicines available worldwide by overcoming the unique challenges of biosimilar production. From navigating complex regulatory pathways to ensuring precision in manufacturing, we bring over 14 years of experience and innovation to deliver affordable, life-saving therapies. Curious about how we tackle these challenges and where the industry is heading? 👉 Check out our latest blog here: https://lnkd.in/dui3wNRK #AccessibleHealthcare #Biopharma #mAbxience #CDMO #Pharmaceuticals #FutureOfMedicine

[ES] 📢 Si estás en Madrid, no te pierdas esta gran sorpresa de BioSim para cerrar la #GlobalBiosimilarsWeek!   👩⚕️ Biosina, la menina de BioSim, ya está aquí, diseñada para acercar los #biosimilares a la ciudadanía de una manera creativa y única. Esta obra es un símbolo del compromiso de BioSim con la promoción de los beneficios de los biosimilares, esenciales para un acceso más equitativo a tratamientos innovadores. 🌍   En mAbxience celebramos iniciativas como esta, que refuerzan la importancia de los biosimilares en la sostenibilidad del sistema de salud y la accesibilidad a medicamentos.   #Biosimilares #GlobalBiosimilarsWeek #Biosina #MeninasMadrid #BioSim #mAbxience   [ENG] 📢 If you’re in Madrid, don’t miss this surprise from BioSim to conclude #GlobalBiosimilarsWeek!   👩⚕️ Meet Biosina, BioSim’s "menina," unveiled to raise awareness about #biosimilars in a creative and impactful way. In Madrid, meninas (decorative statues inspired by Velázquez’s famous painting) are a beloved artistic tradition, making Biosina a perfect ambassador for biosimilar awareness. 🌍   At mAbxience, we celebrate initiatives like this that highlight the critical role of biosimilars in improving healthcare access worldwide.   #Biosimilars #GlobalBiosimilarsWeek #Biosina #MeninasMadrid #BioSim #mAbxience  

At mAbxience, our mission is simple: Helping people live better by making high-quality, affordable medicines accessible worldwide. 🌍💊 🎥 Hear it from our team! In this new video from the #withinmAbxience series, Neel Mehta, our Regulatory Affairs Manager, shares how his work plays a vital role in achieving that mission by ensuring approvals across different regulatory agencies. Watch the full video to see how our team is making a difference! Want to learn more about our biopharmaceutical development pipeline? Visit our website! https://lnkd.in/dWN5NYFt #GlobalBiosimilarsWeek #HelpingPeopleLiveBetter #AffordableHealthcare #RegulatoryAffairs #mAbxience #Biosimilars

We are pleased to announce a new strategic partnership with Egis Pharmaceuticals PLC through a strategic license agreement for the commercialization of two biosimilar candidates. This collaboration reinforces our shared commitment to providing high-quality, affordable biosimilar therapies to patients in key Central and Eastern European markets, including Hungary, Poland, Czech Republic, Slovakia, Romania, Bulgaria, Latvia, and Lithuania, with the potential to expand into additional territories. Read the full press release to learn more about this exciting next step in our journey: https://lnkd.in/dbVpxE26 #biosimilars #partnership #healthcare #pharma #innovation #mAbxience #Egis #globalhealth

#GlobalBiosimilarsWeek is here, and this year we’re focusing on how biosimilars are transforming healthcare by increasing affordable access for patients worldwide. 💊🌍 At mAbxience, we’re proud to contribute to this mission. With our expertise in development and manufacturing of biopharmaceuticals, we are helping ensure that high-quality medicines reach patients across the globe. ✅ Faster market entry ✅ Cost-effective treatments ✅ Strong regulatory relationships to overcome global barriers 👉 Learn more about our biopharmaceutical development expertise: https://lnkd.in/dWN5NYFt #GlobalBiosimilarsWeek #AccessToBiosimilars #AffordableHealthcare #BiosimilarInnovation #mAbxience

🚀 New Blog Alert! 🚀 CDMOs are transforming healthcare by bringing life-saving therapies to market faster than ever! At mAbxience, we’re proud to play a key role in this movement with our flexible, end-to-end CDMO solutions. From supporting AstraZeneca with over 200 million COVID-19 vaccine doses in record time to building a robust portfolio of biologics, we’re helping redefine what’s possible in modern medicine. 🌍💊 Curious about how CDMOs like mAbxience are paving the way for the future of healthcare? Check out our latest blog to learn more! 👉 https://lnkd.in/diwzp5v3 #Biopharma #CDMO #HealthcareInnovation #VaccineManufacturing #Pharmaceuticals #Biologics #mAbxience #Biotech #FutureOfHealthcare #EndToEndSolutions

At mAbxience, we use cutting-edge similarity tests to ensure our biosimilars match their reference products in quality, efficacy, and safety. Our analytical methods guarantee that every biosimilar meets the standards for global patient access. Curious about the science behind it? Watch our video to learn how advanced techniques like mass spectrometry and chromatography play a critical role in this process. 🎥 Watch the video to explore the key steps in biosimilar development! 👉 https://lnkd.in/gAGXxsc Learn more about our biopharmaceutical development expertise: https://lnkd.in/dWN5NYFt #GlobalBiosimilarsWeek #BiosimilarScience #SimilarityTests #AffordableMedicines #BiopharmaInnovation #mAbxience